Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Assembly Biosciences (ASMB) Assets Average: 2015-2025

Historic Assets Average for Assembly Biosciences (ASMB) over the last 11 years, with Sep 2025 value amounting to $160.4 million.

  • Assembly Biosciences' Assets Average rose 48.79% to $160.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $160.4 million, marking a year-over-year increase of 48.79%. This contributed to the annual value of $128.0 million for FY2024, which is 7.28% up from last year.
  • Assembly Biosciences' Assets Average amounted to $160.4 million in Q3 2025, which was up 78.41% from $89.9 million recorded in Q2 2025.
  • In the past 5 years, Assembly Biosciences' Assets Average ranged from a high of $281.1 million in Q1 2021 and a low of $59.1 million during Q3 2023.
  • In the last 3 years, Assembly Biosciences' Assets Average had a median value of $107.8 million in 2024 and averaged $104.0 million.
  • In the last 5 years, Assembly Biosciences' Assets Average slumped by 55.39% in 2023 and then skyrocketed by 82.38% in 2024.
  • Quarterly analysis of 5 years shows Assembly Biosciences' Assets Average stood at $220.0 million in 2021, then slumped by 49.25% to $111.7 million in 2022, then dropped by 15.61% to $94.2 million in 2023, then rose by 16.44% to $109.7 million in 2024, then soared by 48.79% to $160.4 million in 2025.
  • Its Assets Average was $160.4 million in Q3 2025, compared to $89.9 million in Q2 2025 and $109.1 million in Q1 2025.